Challenges of switching towards anti-CD20 monoclonal antibodies in RR-MS: A monocentric study.

MLA

Boudot de la Motte, Marine, et al. “Challenges of Switching towards Anti-CD20 Monoclonal Antibodies in RR-MS: A Monocentric Study.” Multiple Sclerosis and Related Disorders, vol. 52, July 2021, p. 102981. EBSCOhost, https://doi.org/10.1016/j.msard.2021.102981.

APA

Boudot de la Motte, M., Louapre, C., Papeix, C., Depaz, R., Assouad, R., Roux, T., Lubetzki, C., & Maillart, E. (2021). Challenges of switching towards anti-CD20 monoclonal antibodies in RR-MS: A monocentric study. Multiple Sclerosis and Related Disorders, 52, 102981. https://doi.org/10.1016/j.msard.2021.102981

Chicago

Boudot de la Motte, Marine, Céline Louapre, Caroline Papeix, Raphaël Depaz, Rana Assouad, Thomas Roux, Catherine Lubetzki, and Elisabeth Maillart. 2021. “Challenges of Switching towards Anti-CD20 Monoclonal Antibodies in RR-MS: A Monocentric Study.” Multiple Sclerosis and Related Disorders 52 (July): 102981. doi:10.1016/j.msard.2021.102981.